Loading clinical trials...
Loading clinical trials...
The proposed study is a randomized, double-blind, placebo-controlled, multi-center Phase II study to investigate the safety and efficacy of SHR0302 in patients with moderate to severe active Crohn's D...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Reistone Biopharma Company Limited
NCT06226883 · Inflammatory Bowel Diseases, Crohn's Disease
NCT07184931 · Crohn's Disease
NCT06918808 · Perianal Fistula Due to Crohn's Disease
NCT06647615 · Crohn's Disease, Abdominal Pain (AP)
NCT07377188 · IBD, Crohn's Disease, and more
West Central Gastroenterology d/b/a Gastro Florida
Clearwater, Florida
Wellness Clinical Research, LLLC-Central Florida
Lake Wales, Florida
West Central Gastroenterology d/b/a Gastro Florida
Tampa, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions